OBJECTIVE: Recent studies reported that women with homozygous alleles for serine (S) in both FSHR (rs 6166) and LHCGR (rs 2293275) polymorphisms had a 40% higher chance of live birth compared to those with other genotypes after in vitro fertilization (IVF) cycle. Given the major repercussions that these findings might bring to clinical practice, this study aimed to investigate any association between different polymorphism combinations of both FSHR and LHCGR and clinical outcomes in IVF cycles with preimplantation genetic testing for aneuploidy (PGT-A), therefore controlling for the embryo ploidy status. DESIGN: Retrospective cohort study.
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MATERIALS AND METHODS: All women age 18-40 undergoing their first IVF cycle with aneuploidy screening between 2006-2017 with body mass index <40 were included. All patients received both recombinant FSH and hMG. GenomicDNAwas isolated from patient's blood. For the genotyping of the aforementioned variants, allelic discrimination for the FSHR and LHCGR receptor polymorphisms were performed using TaqMan genotyping assays. Associations between both receptor genotypes and clinical -12.47 77.1%(75.0-79.1) 42.1%(39.3-44.8) 53.2%(42.6-63.6 ) 50.4%(41.1-59.7) 51.1%(40.5-61.5) P value 0.2082 2.07x10-6 0.118 0.234 0.344 0.237 FERTILITY & STERILITY_ e59 outcomes was assessed using generalized regression and ANOVA. Live birth rate was the primary outcome. Secondary outcomes included: oocyte yield, mature oocytes (MII) rate, blastocyst rate, usable blastocyst rate, and implantation rate.
RESULTS: 1183 patients met the inclusion criteria and generated reliable genotype calls. The overall genotype frequencies in the study population for the FSHR gene were: 21.7% homozygous for S in codon 680, 29.2% homozygous for N680 and 48.1% heterozygous
